Month: October 2022

Reactive oxygen species contribute to delirium-like behavior by activating CypA/MMP9 signaling and inducing blood-brain barrier impairment in aged mice following anesthesia and surgery

Postoperative delirium (POD) is common in the elderly and is associated with poor clinical outcomes. Reactive oxygen species (ROS) and blood-brain barrier (BBB) damage have been implicated in the development of POD, but the association between these two factors and the potential mechanism is not clear. Cyclophilin A (CypA) is a specifically chemotactic leukocyte factor […]

Published on October 19, 2022

CDC Committee Advocates for Free Child COVID Vaccines

The CDC Advisory Committee has given a thumbs up to adding COVID-19 vaccines to the CDC’s child vaccine program, which already offers free inoculations for various diseases to millions of children. Picture it like this: imagine your fridge, already full of nutritious fruits and veggies, now adding a carton of refreshing orange juice to the […]

Published on October 19, 2022

Diabetes Medications: Lower Dementia Risk

A recent study suggests that certain diabetes medications could reduce the risk of developing dementia. Specifically, an older class of drugs known as thiazolidinediones (TZDs), or glitazones, may provide a protective effect. According to the research, TZDs can decrease the risk of dementia by 22% in individuals who are at a high risk and already […]

Published on October 19, 2022